Preventive medicine reports
-
Opioid overdose fatalities include deaths from natural opioids (morphine and codeine), semi-synthetic opioids (oxycodone, hydrocodone), synthetic opioids (prescription and illicit fentanyl, tramadol), methadone, and heroin. From 1999 to 2017, there were 702,568 drug overdose deaths in the U. S., with 399,230 attributed to opioids. ⋯ The changing dynamics of fatal opioid overdose at the state level is critical to guiding policy makers in addressing this crisis. Rates of fatal opioid overdose vary across the states, but we identify some trends. Regional differences are identified in states with the highest overdose rates from all opioids combined.
-
Regular physical activity is a key modifiable non-pharmacological treatment to enhance sleep quality, a key predictor of optimal health and wellbeing. Most of the evidence on physical activity and sleep quality is based on studies assessing the effects of aerobic moderate-to-vigorous physical activity (e.g. brisk walking, cycling, jogging). Emerging clinical evidence suggests that muscle-strengthening exercise (e.g. push-ups, using weight machines) may also be beneficial for sleep quality. ⋯ Poisson regression with robust error variance was used to calculate prevalence ratios of (PR) across weekly muscle-strengthening exercise frequency (None [reference]; 1, 2, 3-4 and ≥ 5 times/week), adjusting for potential confounders (e.g. age, sex, socioeconomic status, self-rated health, smoking, alcohol, aerobic physical activity). Compared with those reporting none, any muscle-strengthening exercise was associated with a reduced prevalence of 'poor' (PR range: 0.77-0.83) and 'very poor' (PR range: 0.57-0.70) quality sleep. Future health behavior modification strategies to enhance sleep quality at the population-level should consider promoting muscle-strengthening exercise.
-
Non-response in prevention programs for cardiometabolic diseases (CMD) in primary care is often overlooked. The aim for this study was to define factors that influence the primary response to a selective CMD prevention program and to determine response-enhancing strategies that influence the willingness to participate. We conducted a non-response analysis within a randomized controlled trial evaluating a selective CMD prevention program, the study was conducted from 2013 to 2018 in Netherlands. ⋯ Although a relatively high proportion did not respond to the invitation for the risk score, the majority of them indicated to be willing to participate if a different invitation strategy would be used. With more time and energy, response rates for CMD prevention programs could possibly increase substantially. A next logical step in this process is to test potential response enhancing strategies in research setting.
-
Appalachian youth tobacco use rates exceed the national average. Additional inquiry is needed to better understand youth product perceptions and use patterns. This study examined tobacco harm perceptions and their relationship with tobacco use among Appalachian youth. ⋯ Compared to never users, e-cigarette only users were more likely to disagree that smoking (AOR: 2.99, 95% CI: 1.30-6.90) and e-cigarettes cause health problems (AOR: 2.79, 95% CI: 1.64-4.75) and that e-cigarettes cause addiction (AOR: 2.48, 95% CI: 1.48-4.16). Most youth were aware of health dangers associated with smoking, but perceptions were split on whether e-cigarettes were associated with health problems or addiction. The findings indicate the need for additional youth tobacco use prevention efforts.
-
Clinical guidelines endorse either a 30 or 20 pack-year smoking history threshold when determining eligibility for lung cancer screening (LCS). However, self-reported smoking history is subject to recall bias that can affect patient eligibility. We examined the reliability of smokers' self-reported tobacco use and its impact on eligibility for LCS. ⋯ Smokers' self-reported tobacco use appears highly reliable over short time periods. Nevertheless, there is some inconsistent reporting. We recommend that clinicians carefully assess smoking history, probe patients' recall of duration and quantity of smoking, and collect tobacco use information at every encounter.